CuraMedical B.V.

Business focus: CuraMedical’s mission is “To become a leading medical device company specializing in the supply of value-added products in wound management and diagnostics, contributing to public healthcare and focussing on leading edge technology products which are manufactured at a competitive price”.

CuraMedical B.V.
Industrieweg 6
1566 JP Assendelft
Website CuraMedical B.V.
E-mail CuraMedical B.V.
T +31 (0)75 657 18 85
F +31 (0)75 657 11 84

Employees in Amsterdam: 4
Employees in R&D: 1
Year of foundation: 1998

Company profile

CuraMedical BV is a medical device company operating in the wound management sector and based in the Netherlands. The key strategic goals of CuraMedical are the manufacture and marketing of haemostatic agents and cytological biopsy instruments.

Science and Technologies or Services

CuraMedical entered the healthcare business in 1995 marketing Curaspon®, an absorbable haemostatic agent based on pharmaceutical gelatin. Nowadays Curaspon® is distributed to more than 60 countries world wide. In 2008 we started to market Curacel®, an absorbable oxidized regenerated cellulose gauze.

Alliances

University Hospitals Worldwide

Keywords

Haemostats;
Gelatine sponge;
Oxidized Regenerated Cellulose gauze;
Pengrip fine needle Biopsy Instrument.

Document Actions

Send this

Penny-wise!

Synaps bij column Arjen Brussaard, foto CNCR.nl

By Arjen Brussaard

Recently the topsector plan Life Sciences & Health was published and presented to Minister Verhagen, of the so-called ELI Ministry. The document is an amazing compressed 60-pager, based on months of hard work by the group of experts chaired by Roel Fonville, and summarizes the conclusions after dozens of 1-to-1 meetings, five regional group sessions with dozens of opinion leaders and after having received over 170 (!) memo's, white papers and letters of intent.
More...

Personal tools